Condition
IgG4-Related Diseases clinical trials and research
As of November 12, 2026, Find a Trial lists 6 IgG4-Related Diseases clinical trials that are recruiting, at sites in 3 countries (most in China (4), Ukraine (1), Germany (1)). By phase: Phase 1 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3Countries
Newest IgG4-Related Diseases clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Odesa Criteria 2026: tests for autoimmune pancreatitis diagnosis | — | Odesa and 1 other locations | Recruiting | Apr 17, 2026 |
| FAPI PET/CT to find tiny remaining IgG4‑RD lesions and guide treatment | — | Beijing, Beijing Municipality | Recruiting | Aug 5, 2025 |
| YTS109 cell therapy for relapsed or refractory systemic autoimmune diseases | Phase 1 | Beijing, Beijing Municipality | Recruiting | May 18, 2025 |
| BCMA-CD19 CAR-T therapy for autoimmune diseases | Phase 2 | Beijing, Beijing Municipality | Recruiting | Jan 27, 2025 |
| Investigating the Role of Y Chromosome Mutations in Autoimmune Diseases | — | Bonn, North Rhine-Westphalia | Recruiting | Nov 19, 2024 |
| FKC288 treatment for autoimmune kidney diseases | Phase 1 | Nanjing, Jiangsu | Recruiting | Feb 29, 2024 |
All recruiting trials (6)
-
Odesa Criteria 2026: tests for autoimmune pancreatitis diagnosis
This study checks if the OC26 scoring system can accurately diagnose autoimmune pancreatitis in adults who may have AIP or related pancreatic diseases.
-
FAPI PET/CT to find tiny remaining IgG4‑RD lesions and guide treatment
This trial will test whether a new 68Ga‑FAPI PET/CT scan can find tiny leftover disease and help decide whether adults with IgG4‑related disease in clinical remission need ongoing treatment.
-
YTS109 cell therapy for relapsed or refractory systemic autoimmune diseases
This trial will try a single infusion of YTS109 cells to see if it's safe and helps adults 18–65 with relapsed or refractory systemic autoimmune diseases such as SLE, systemic sclerosis, inflammatory myopathies, ANCA-associated vasculitis, or antiphospholipid syndrome.
-
BCMA-CD19 CAR-T therapy for autoimmune diseases
This study is testing a new CAR-T cell therapy to see if it can help adults with tough autoimmune diseases feel better and improve their health.
-
Investigating the Role of Y Chromosome Mutations in Autoimmune Diseases
This study is trying to see how changes in the Y chromosome might affect the immune system and contribute to autoimmune diseases like Giant Cell Arteritis and Polymyalgia Rheumatica.
-
FKC288 treatment for autoimmune kidney diseases
This study is testing a new treatment called FKC288 to see if it can help people with tough autoimmune kidney diseases like lupus nephritis and ANCA-associated vasculitis.
Related topics
Quick answers
How many IgG4-Related Diseases clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (4 trials), Ukraine (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.